Expedia Vs. Travelzoo: Which Travel Stock Is A Better Investment?

man sitting on gang chair with feet on luggage looking at airplane

Source: Unsplash 

Travel stocks have significantly weakened over the last few months as the most recent wave of the coronavirus depressed the outlook. However, there are some glimmers of hope as cases are sharply down in many of the hardest-hit states and on a national level as well.

If case counts continue to drop, then this could be a fantastic buy-the-dip opportunity for investors.

Below, we shine the spotlight on two of the travel industry’s top stocks in Expedia (EXPE) and Travelzoo (TZOO).


EXPE is renowned for its online travel services. The company provides travel planning, experience sharing and most importantly, the opportunity to purchase travel arrangements with a few keystrokes and mouse clicks.

EXPE is priced near the halfway point between its 52-week low of $87.90 and its 52-week high of $187.93. Investors don’t seem to have a strong feeling about this stock, largely because no one knows if the pandemic will worsen to the point that the masses fear air travel in those cramped cylindrical steel tube germ centers commonly referred to as airplanes.

EXPE has a beta of 1.71. This is a reasonable figure that indicates the stock will move with the market yet probably won’t prove egregiously volatile.

Check out EXPE’s POWR Rating performance and you will find it is a mixed bag. Overall, the stock has a C POWR Rating grade, meaning it is a Hold. EXPE has B grades in the Quality, Value, and Growth components of the POWR Ratings. The stock has an F Sentiment component grade. Click here to find out how EXPE fares in the remainder of the POWR Ratings components including Momentum and Stability.

EXPE is ranked 10th out of the 75 stocks in the Internet segment. Investors are encouraged to study up on this industry by clicking here.

The analysts are pounding the table in favor of EXPE. If EXPE reaches the analysts’ average target price of $180.50, it will have increased by slightly more than 21% in value. The stock’s average analyst price target has increased $81.30 in the previous 45 weeks. A total of 32 analysts have provided EXPE recommendations. Out of these analysts, four consider the stock to be a Strong Buy, 10 consider it to be a Buy, and 18 view it as a Hold.

1 2
View single page >> |

Disclaimer: Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.